<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>37</Volume>
				<Issue>526</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Index</ArticleTitle>
<VernacularTitle>Index</VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">15846</ELocationID>
			
<ELocationID EIdType="doi">10.22122/jims.v37i526.13221</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Journal</FirstName>
					<LastName>Index</LastName>
<Affiliation>--</Affiliation>
<Identifier Source="ORCID">0000-0003-0874-1906</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>07</Month>
					<Day>15</Day>
				</PubDate>
			</History>
		<Abstract>Click to download the index of this issue.</Abstract>
			<OtherAbstract Language="FA">Click to download the index of this issue.</OtherAbstract>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_15846_e8630344970962450dbedfcd4cc6d718.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>37</Volume>
				<Issue>526</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Expression of Cytokeratin 19 (CK19) and Vascular Endothelial Growth Factor (VEGF) Genes in Peripheral Blood of Patients with Oral Squamous Cell Carcinoma (OSCC)</ArticleTitle>
<VernacularTitle>Expression of Cytokeratin 19 (CK19) and Vascular Endothelial Growth Factor (VEGF) Genes in Peripheral Blood of Patients with Oral Squamous Cell Carcinoma (OSCC)</VernacularTitle>
			<FirstPage>480</FirstPage>
			<LastPage>484</LastPage>
			<ELocationID EIdType="pii">15847</ELocationID>
			
<ELocationID EIdType="doi">10.22122/jims.v37i526.11826</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Parisa</FirstName>
					<LastName>Nabavi</LastName>
<Affiliation>Department of Cellular and Molecular Biology, School of Advanced Science and Technology, Tehran Medical Branch, Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0302-6241</Identifier>

</Author>
<Author>
					<FirstName>Abdolreza</FirstName>
					<LastName>Mohamadnia</LastName>
<Affiliation>Assistant Professor, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD) AND Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Naseroleslami</LastName>
<Affiliation>Assistant Professor, Department of Cellular and Molecular Biology, School of Advanced Science and Technology, Tehran Medical Branch, Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9163-7346</Identifier>

</Author>
<Author>
					<FirstName>Naghmeh</FirstName>
					<LastName>Bahrami</LastName>
<Affiliation>Assistant Professor, Craniomaxillofacial Research Center AND Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-3575-4094</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>05</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>Background: Oral squamous cell carcinoma (OSCC) is one of the 10 most common malignant tumors. This study aimed to evaluate the relevance of vascular endothelial growth factor (VEGF) and cytokeratin 19 (CK19) genes as biomarkers for diagnosis of OSCC.Methods: In this study, 30 patients and 30 healthy individuals were selected. CK19 and VEGF were measured in peripheral blood using real-time polymerase chain reaction (PCR) technique. T-test was performed to analyze the data.Findings: In patients with OSCC, CK19 and VEGF markers were positive in 17 and 23 patients out of 30.Conclusion: The expression of VEGF and CK19 is more among the patients with OSCC, compared to healthy people. In summary, the result of this study can be considered as a diagnostic screening test in the early stages of the disease.</Abstract>
			<OtherAbstract Language="FA">Background: Oral squamous cell carcinoma (OSCC) is one of the 10 most common malignant tumors. This study aimed to evaluate the relevance of vascular endothelial growth factor (VEGF) and cytokeratin 19 (CK19) genes as biomarkers for diagnosis of OSCC.Methods: In this study, 30 patients and 30 healthy individuals were selected. CK19 and VEGF were measured in peripheral blood using real-time polymerase chain reaction (PCR) technique. T-test was performed to analyze the data.Findings: In patients with OSCC, CK19 and VEGF markers were positive in 17 and 23 patients out of 30.Conclusion: The expression of VEGF and CK19 is more among the patients with OSCC, compared to healthy people. In summary, the result of this study can be considered as a diagnostic screening test in the early stages of the disease.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Head and neck squamous cell carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cytokeratin 19</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Vascular endothelial growth factor</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_15847_2c6037040bf5058a44be4c0397611909.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>37</Volume>
				<Issue>526</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Impact of Early Endurance Training on Improvement of Brain Damage in CA1 Region of Hippocampus and Expression of A2A Protein Following Ischemic Stroke in Rats</ArticleTitle>
<VernacularTitle>Impact of Early Endurance Training on Improvement of Brain Damage in CA1 Region of Hippocampus and Expression of A2A Protein Following Ischemic Stroke in Rats</VernacularTitle>
			<FirstPage>485</FirstPage>
			<LastPage>492</LastPage>
			<ELocationID EIdType="pii">15848</ELocationID>
			
<ELocationID EIdType="doi">10.22122/jims.v37i526.11962</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Seydyousefi</LastName>
<Affiliation>Department of Physical Education and Sport Sciences, School of Humanities, Bojnourd Branch, Islamic Azad University, Bojnourd, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9102-9463</Identifier>

</Author>
<Author>
					<FirstName>Ziya</FirstName>
					<LastName>Fallahmohammadi</LastName>
<Affiliation>Associate Professor, Department of Exercise Physiology, School of Sport Sciences, University of Mazandaran, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-9214-0195</Identifier>

</Author>
<Author>
					<FirstName>Mahtab</FirstName>
					<LastName>Moazzami</LastName>
<Affiliation>Associate Professor, Department of Exercise Physiology, School of Sport Sciences, Ferdowsi University of Mashhad, Mashhad, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-6422-2935</Identifier>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Yaghoubi</LastName>
<Affiliation>Assistant Professor, Department of Physical Education and Sport Sciences, School of Humanities, Bojnourd Branch, Islamic Azad University, Bojnourd, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8043-5455</Identifier>

</Author>
<Author>
					<FirstName>Zeinab</FirstName>
					<LastName>Faghfoori</LastName>
<Affiliation>PhD of Nutrition, Food Safety Research Center (Salt), Semnan University of Medical Sciences, Semnan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-5312-6585</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>Background: Brain ischemia/reperfusion causes structural and functional damage in the hippocampus. Physical activity is an essential method for early rehabilitation after a stroke. The aim of this study was to determine the effect of 8 weeks of early endurance training on treadmill on improvement of the neurons of CA1 region of hippocampus and expression of A2A protein following cerebral ischemia/reperfusion in male rats.Methods: 21 male Wistar rats were randomly divided into three groups of sham, ischemia + control, and ischemia + exercise. 24 hours after induction of ischemia, the rats in exercise group ran 5 days a week, for 8 weeks. Ischemia was induced by blocking both common carotid arteries for 45 minutes. Ladder test, hematoxylin and eosinophil (H&amp;E) staining, and immunohistochemical method were used to evaluate functional status, neuronal death, and protein expression, respectively.Findings: The brain ischemia was associated with an increase in neuronal death in the CA1 region of hippocampus, and reduced cognitive function and motor learning. Early training significantly decreased cell death, as well as impaired cognitive function and motor learning. Moreover, in ischemia + exercise group, expression of A2A did not change significantly compared to the ischemia + control group.Conclusion: This study showed that early training on treadmill, as a rehabilitation stimulant, would have protective effects against cell death, and can improve motor function.</Abstract>
			<OtherAbstract Language="FA">Background: Brain ischemia/reperfusion causes structural and functional damage in the hippocampus. Physical activity is an essential method for early rehabilitation after a stroke. The aim of this study was to determine the effect of 8 weeks of early endurance training on treadmill on improvement of the neurons of CA1 region of hippocampus and expression of A2A protein following cerebral ischemia/reperfusion in male rats.Methods: 21 male Wistar rats were randomly divided into three groups of sham, ischemia + control, and ischemia + exercise. 24 hours after induction of ischemia, the rats in exercise group ran 5 days a week, for 8 weeks. Ischemia was induced by blocking both common carotid arteries for 45 minutes. Ladder test, hematoxylin and eosinophil (H&amp;E) staining, and immunohistochemical method were used to evaluate functional status, neuronal death, and protein expression, respectively.Findings: The brain ischemia was associated with an increase in neuronal death in the CA1 region of hippocampus, and reduced cognitive function and motor learning. Early training significantly decreased cell death, as well as impaired cognitive function and motor learning. Moreover, in ischemia + exercise group, expression of A2A did not change significantly compared to the ischemia + control group.Conclusion: This study showed that early training on treadmill, as a rehabilitation stimulant, would have protective effects against cell death, and can improve motor function.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Endurance training</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ischemia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Reperfusion</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_15848_69eb1fa7a8b30d8e7bcfc61f5c9c7d96.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>37</Volume>
				<Issue>526</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Effects of Plasma-Activated Medium on the Viability of Breast (MDA-MB-231) and Cervical (Hela) Cancer Cell Lines</ArticleTitle>
<VernacularTitle>The Effects of Plasma-Activated Medium on the Viability of Breast (MDA-MB-231) and Cervical (Hela) Cancer Cell Lines</VernacularTitle>
			<FirstPage>493</FirstPage>
			<LastPage>499</LastPage>
			<ELocationID EIdType="pii">15849</ELocationID>
			
<ELocationID EIdType="doi">10.22122/jims.v37i526.10308</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mahya</FirstName>
					<LastName>Aminraya-Jezeh</LastName>
<Affiliation>Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7736-1232</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Reza</FirstName>
					<LastName>Khani</LastName>
<Affiliation>Assistant Professor, Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Shokri</LastName>
<Affiliation>Professor, Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8242-5111</Identifier>

</Author>
<Author>
					<FirstName>Hassan</FirstName>
					<LastName>Niknejad</LastName>
<Affiliation>Associate Professor, Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>06</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract>Background: Plasma is used in two direct and indirect methods for treating cancer cells. Direct treatment of cells or tissues is carried out with irradiation of plasma, but in indirect treatment, the medium activated by plasma radiation is used to decrease cancer cell growth.Methods: In this experimental study, the plasma parameters such as active species and temperature were evaluated, and then the effects of plasma-activated medium in different treatment times and gas composition of helium/helium + 0.5% oxygen were investigated on two cancer cell lines of Hela and MDA-MB-231. Moreover, to evaluate the selectivity effects of the plasma-activated medium, the viability of normal fibroblast cell lines was investigated after direct and indirect treatments. Analyses used in this study were optical emission spectroscopy (OES) and MTT assay.Findings: The optimal state for the experiments was 1 cm distance between the sample and the nozzle of the plasma jet and the voltage of 5 kV. Moreover, increasing the time of treatment of the medium and interval time between treatment and analysis caused decreasing in cancer cells viability. The plasma-activated medium also reduced the viability of cancer cells more than that of normal cells.Conclusion: Plasma-activated medium is a new and challenging method, which has a selective toxicity to destroy cancer cells. Based on the results, cold atmospheric plasma could be an effective and alternative method for cancer therapy.</Abstract>
			<OtherAbstract Language="FA">Background: Plasma is used in two direct and indirect methods for treating cancer cells. Direct treatment of cells or tissues is carried out with irradiation of plasma, but in indirect treatment, the medium activated by plasma radiation is used to decrease cancer cell growth.Methods: In this experimental study, the plasma parameters such as active species and temperature were evaluated, and then the effects of plasma-activated medium in different treatment times and gas composition of helium/helium + 0.5% oxygen were investigated on two cancer cell lines of Hela and MDA-MB-231. Moreover, to evaluate the selectivity effects of the plasma-activated medium, the viability of normal fibroblast cell lines was investigated after direct and indirect treatments. Analyses used in this study were optical emission spectroscopy (OES) and MTT assay.Findings: The optimal state for the experiments was 1 cm distance between the sample and the nozzle of the plasma jet and the voltage of 5 kV. Moreover, increasing the time of treatment of the medium and interval time between treatment and analysis caused decreasing in cancer cells viability. The plasma-activated medium also reduced the viability of cancer cells more than that of normal cells.Conclusion: Plasma-activated medium is a new and challenging method, which has a selective toxicity to destroy cancer cells. Based on the results, cold atmospheric plasma could be an effective and alternative method for cancer therapy.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Reactive oxygen species</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cell lines</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cell viability</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Spectroscopy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_15849_b150a8c54f717b966fee06d0b7e49f6f.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>37</Volume>
				<Issue>526</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparing the Velocity of Haloperidol, Chlorpromazine, Trifluoperazine, and Promethazine in Sedating of Aggressive Patients</ArticleTitle>
<VernacularTitle>Comparing the Velocity of Haloperidol, Chlorpromazine, Trifluoperazine, and Promethazine in Sedating of Aggressive Patients</VernacularTitle>
			<FirstPage>500</FirstPage>
			<LastPage>507</LastPage>
			<ELocationID EIdType="pii">15850</ELocationID>
			
<ELocationID EIdType="doi">10.22122/jims.v37i526.11204</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Sayed Ghafour</FirstName>
					<LastName>Mousavi</LastName>
<Affiliation>Professor, Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-1921-0377</Identifier>

</Author>
<Author>
					<FirstName>Delaram</FirstName>
					<LastName>Eghtesadi</LastName>
<Affiliation>Resident, Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0521-0192</Identifier>

</Author>
<Author>
					<FirstName>Behzad</FirstName>
					<LastName>Mahaki</LastName>
<Affiliation>Associate Professor, Department of Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7062-6971</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>12</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>Background: Aggression is a threatening hurtful sign occurring by a variety of causes, and should be managed rapidly by therapists. To this end, anti-psychotic drugs are used. It is essential to identify the medications that are more rapidly efficient, and can calm an aggressive patient. This study attempted to compare the velocity of haloperidol, trifluoperazine, promethazine, and chlorpromazine in sedating of aggressive patients.Methods: This was a randomized clinical trial study on aggressive patients referred to the psychiatry emergency department of Nour hospital, Isfahan, Iran, from 2016 to 2017. 76 patients were randomly divided into 4 groups, and respectively received haloperidol, promethazine, chlorpromazine, and trifluoperazine intramuscularly. Patients were evaluated each 30 minutes for aggressive symptoms. The time last for sedation was recorded for each patient, too.Findings: 76 patients with the mean age of 32.85 ± 7.80 years participated in this study, and 61.8% of them were men. 59.2% showed respond to intervention after the first injection, and 40.8% needed the second injection. The mean time needed for obtaining sedation was 19.41 ± 6.61 and 18.71 ± 5.38 minutes after the first and second injection, respectively. These mean times of sedation induction were not significantly related to age, gender, type of substance used, and type of aggression. After the first and second injection, the shortest time needed of sedation induction was in promethazine group and the longest one was in chlorpromazine group.Conclusion: Promethazine has the highest speed in creating sedative effects on aggressive patients. None of the studied drugs produced any side effect.</Abstract>
			<OtherAbstract Language="FA">Background: Aggression is a threatening hurtful sign occurring by a variety of causes, and should be managed rapidly by therapists. To this end, anti-psychotic drugs are used. It is essential to identify the medications that are more rapidly efficient, and can calm an aggressive patient. This study attempted to compare the velocity of haloperidol, trifluoperazine, promethazine, and chlorpromazine in sedating of aggressive patients.Methods: This was a randomized clinical trial study on aggressive patients referred to the psychiatry emergency department of Nour hospital, Isfahan, Iran, from 2016 to 2017. 76 patients were randomly divided into 4 groups, and respectively received haloperidol, promethazine, chlorpromazine, and trifluoperazine intramuscularly. Patients were evaluated each 30 minutes for aggressive symptoms. The time last for sedation was recorded for each patient, too.Findings: 76 patients with the mean age of 32.85 ± 7.80 years participated in this study, and 61.8% of them were men. 59.2% showed respond to intervention after the first injection, and 40.8% needed the second injection. The mean time needed for obtaining sedation was 19.41 ± 6.61 and 18.71 ± 5.38 minutes after the first and second injection, respectively. These mean times of sedation induction were not significantly related to age, gender, type of substance used, and type of aggression. After the first and second injection, the shortest time needed of sedation induction was in promethazine group and the longest one was in chlorpromazine group.Conclusion: Promethazine has the highest speed in creating sedative effects on aggressive patients. None of the studied drugs produced any side effect.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Haloperidol</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chlorpromazine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Trifluoperazine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Promethazine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Aggression</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_15850_0b1ec7225cc65947854e79e7a58c63bc.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>37</Volume>
				<Issue>526</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Sexual Self-Efficacy and its Predictor Factors in Women with Multiple Sclerosis</ArticleTitle>
<VernacularTitle>Sexual Self-Efficacy and its Predictor Factors in Women with Multiple Sclerosis</VernacularTitle>
			<FirstPage>508</FirstPage>
			<LastPage>516</LastPage>
			<ELocationID EIdType="pii">15851</ELocationID>
			
<ELocationID EIdType="doi">10.22122/jims.v37i526.11827</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Vida</FirstName>
					<LastName>Ghasemi</LastName>
<Affiliation>PhD Candidate of Reproductive Health, Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-9966-1604</Identifier>

</Author>
<Author>
					<FirstName>Masoumeh</FirstName>
					<LastName>Simbar</LastName>
<Affiliation>Professor, Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2843-3150</Identifier>

</Author>
<Author>
					<FirstName>Giti</FirstName>
					<LastName>Ozgoli</LastName>
<Affiliation>Associate Professor, Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2111-7024</Identifier>

</Author>
<Author>
					<FirstName>Seyed Massood</FirstName>
					<LastName>Nabavi</LastName>
<Affiliation>Associate Professor, Department of Brain and Cognitive Sciences, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-9814-8083</Identifier>

</Author>
<Author>
					<FirstName>Hamid</FirstName>
					<LastName>Alavi-Majd</LastName>
<Affiliation>Professor, Department of Biostatistics, School of Paramedicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7772-2923</Identifier>

</Author>
<Author>
					<FirstName>Maryam Sadat</FirstName>
					<LastName>Mirshafaei</LastName>
<Affiliation>Department of Psychometrics, School of Psychology and Educational Sciences, Allameh Tabatabaei University Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9245-9684</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>05</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>Background: Sexual problems are prevalent in women with multiple sclerosis (MS), and sexual self-efficacy as an effective variable plays an important role in sexual health and sexual quality of life of these women. The aim of this study was to determine the predictors of sexual self-efficacy in women with multiple sclerosis.Methods: This descriptive analytical study was conducted in Tehran, Iran, with participation of 200 women with MS, who referred to the Iranian MS society, had Expanded Disability Status Scale (EDSS) ≥ 7, and met the inclusion criteria in year 2019; they were selected using convenience sampling method. For data collection and assess the predictor factors of sexual self-efficacy in women with MS, related standard questionnaires were used. Data were analyzed using Pearson correlation coefficient, t-test, one-way ANOVA, and multiple linear regression model via SPSS software.Findings: The mean age of participants was 36.33 ± 5.22 years, and the mean score of sexual self-efficacy was 16.54 ± 7.27. After entering the significant variables derived from measuring the relationship between each variable individually with the score of sexual self-efficacy in multiple linear regression model for controlling confounders, sexual dysfunction (P = 0.001), anxiety (P = 0.024), stress (P = 0.006), and the number of sexual intercourse (P = 0.013) were significantly predictor factors of sexual self-efficacy in women with MS.Conclusion: The sexual dysfunction, anxiety, stress, and the number of sexual intercourse significantly predicted sexual self-efficacy in women with MS. Therefore, considering these factors in the treatment process of these patients can help to promote sexual self-efficacy and empower them in sexual life.</Abstract>
			<OtherAbstract Language="FA">Background: Sexual problems are prevalent in women with multiple sclerosis (MS), and sexual self-efficacy as an effective variable plays an important role in sexual health and sexual quality of life of these women. The aim of this study was to determine the predictors of sexual self-efficacy in women with multiple sclerosis.Methods: This descriptive analytical study was conducted in Tehran, Iran, with participation of 200 women with MS, who referred to the Iranian MS society, had Expanded Disability Status Scale (EDSS) ≥ 7, and met the inclusion criteria in year 2019; they were selected using convenience sampling method. For data collection and assess the predictor factors of sexual self-efficacy in women with MS, related standard questionnaires were used. Data were analyzed using Pearson correlation coefficient, t-test, one-way ANOVA, and multiple linear regression model via SPSS software.Findings: The mean age of participants was 36.33 ± 5.22 years, and the mean score of sexual self-efficacy was 16.54 ± 7.27. After entering the significant variables derived from measuring the relationship between each variable individually with the score of sexual self-efficacy in multiple linear regression model for controlling confounders, sexual dysfunction (P = 0.001), anxiety (P = 0.024), stress (P = 0.006), and the number of sexual intercourse (P = 0.013) were significantly predictor factors of sexual self-efficacy in women with MS.Conclusion: The sexual dysfunction, anxiety, stress, and the number of sexual intercourse significantly predicted sexual self-efficacy in women with MS. Therefore, considering these factors in the treatment process of these patients can help to promote sexual self-efficacy and empower them in sexual life.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Self efficacy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sexual health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sexual dysfunction, Physiological</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Multiple Sclerosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Women</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_15851_ed1f65a161ee1de13bf41dac2781af4f.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
